tiprankstipranks
Trending News
More News >
Instil Bio, Inc. (TIL)
NASDAQ:TIL
US Market

Instil Bio (TIL) Financial Statements

Compare
382 Followers

Instil Bio Financial Overview

Instil Bio's market cap is currently $47.95M. The company's EPS TTM is $-2.01; its P/E ratio is -0.62; Instil Bio is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-2.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 138.00K
Gross Profit$ 0.00$ 0.00$ -5.99M$ 0.00$ 138.00K
Operating Income$ -73.54M$ -159.17M$ -206.17M$ -155.56M$ -33.64M
EBITDA$ -62.53M$ -147.12M$ -217.38M$ -152.51M$ -33.39M
Net Income$ -74.14M$ -156.09M$ -223.18M$ -156.79M$ -37.74M
Balance Sheet
Cash & Short-Term Investments$ 113.31M$ 150.36M$ 260.92M$ 454.10M$ 241.71M
Total Assets$ 263.57M$ 325.63M$ 482.13M$ 609.98M$ 319.01M
Total Debt$ 86.89M$ 86.05M$ 79.90M$ 0.00$ 0.00
Net Debt$ 78.08M$ 76.86M$ 36.19M$ -37.59M$ -241.71M
Total Liabilities$ 94.13M$ 99.80M$ 118.52M$ 54.78M$ 26.64M
Stockholders' Equity$ 169.44M$ 225.83M$ 363.61M$ 555.20M$ 292.37M
Cash Flow
Free Cash Flow$ -65.70M$ -102.69M$ -264.75M$ -179.97M$ -80.43M
Operating Cash Flow$ -55.70M$ -82.03M$ -180.16M$ -122.14M$ -29.62M
Investing Cash Flow$ 53.97M$ 41.13M$ 114.54M$ -474.40M$ -51.12M
Financing Cash Flow$ 1.75M$ 8.08M$ 71.89M$ 393.16M$ 313.05M
Currency in USD

Instil Bio Earnings and Revenue History

Instil Bio Debt to Assets

Instil Bio Cash Flow

Instil Bio Forecast EPS vs Actual EPS